News | December 16, 2010

Balloon Catheter System for Coronary Revascularization Receives CE Mark

December 16, 2010 – A system designed to improve acute coronary syndrome (ACS) revascularization following percutaneous coronary intervention (PCI) has received CE Mark. The PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System, by Miracor Medical Systems can be used during coronary revascularization procedures to intermittently increase the pressure in the coronary venous system.

The catheter incorporates a soft distal atraumatic tip and can be placed from the femoral or jugular vein using a standard coronary sinus sheath or over the wire into the coronary sinus. Two marker bands will clearly show the extension of the balloon in the coronary sinus. The low profile balloon is automatically inflated and deflated based on the measurement of the coronary sinus pressure and the patient ECG.

The catheter is maintained in the coronary sinus using an outer hypotube that is laser cut to provide gradual flexibility for easy access into the coronary sinus. The catheter is connected to the console through two pneumatic tubes in which helium is shuttled to and from the balloon. In addition, the coronary sinus pressure is monitored through the center lumen of the catheter.

"Nearly one in three heart attack patients has troublesome microcirculatory blood flow even after coronary angioplasty, which increases the risk of death within a year by almost 300 percent,” said Jon H. Hoem, CEO of Miracor. “PICSO is designed to benefit these patients."

In 2011, the company will initiate the post CE-Mark RAMSES clinical trial in seven European centers. Professor Jan Piek, Academic Medical Center, Amsterdam, will be the principal investigator.

"As we have seen in the 'Prepare PICSO' study, the Miracor technology reduces ischemia in acute coronary syndrome patients," Piek said. "We believe that the technology can open a completely new way to treat critically ill acute coronary syndrome patients."

For more information:

Related Content

Edwards Lifesciences Recalls IntraClude Intra-aortic Occlusion Device
News | Balloon Catheter | July 15, 2019
Edwards LifeSciences is recalling the IntraClude Intra-Aortic Occlusion Device due to a risk of balloon rupture during...
Gore Molding & Occlusion Balloon for Endovascular Aortic Repair Receives FDA Approval
Technology | Balloon Catheter | August 23, 2018
W. L. Gore & Associates Inc. (Gore) announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Gore...
Cardiovascular Systems Inc. and OrbusNeich Announce FDA Clearance  of Sapphire II Pro 1mm Coronary Balloon
Technology | Balloon Catheter | March 21, 2018
Cardiovascular Systems Inc. (CSI) recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k...
Cardiovascular Systems Expands Product Portfolio for Peripheral and Coronary Interventions
News | Balloon Catheter | January 24, 2018
Cardiovascular Systems Inc. recently announced two new partnerships broadening the company’s product portfolio. CSI is...
Abbott recalls its NC Balloon catheters
News | Balloon Catheter | May 22, 2017
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports
Videos | Balloon Catheter | November 16, 2016
A discussion with Todd Brinton, M.D., about the newly FDA-cleared Shockwave Medical Lithoplasty System, at the Transc
NuCryo Vascular, Next Generation Cryoplasty Inflation Device, PolarCath Balloon Dilatation System

PolarCath Balloon Dilatation System image courtesy of NuCryo Vascular

Technology | Balloon Catheter | March 28, 2016
NuCryo Vascular LLC announced the launch of the Next Generation Cryoplasty Inflation device. The device received U.S....
NuCryo Vascular, FDA clearance, next-gen, PolarCath System, cryoplasty inflation device
Technology | Balloon Catheter | January 12, 2016
NuCryo Vascular LLC announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance on the...
Videos | Balloon Catheter | October 30, 2015
Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford Uni
Overlay Init